NCT05765214Active, not recruiting
Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 13 Mar 2025
Brief summary (registry, in English)
The goal of this observation study is to deliver an education program designed to increase knowledge of colorectal cancer prevention and nutrition education in minorities with Type 2 diabetes. The main questions it aims to answer are: * What factors are associated with colorectal cancer screening among patients with type 2 diabetes? * Will implementing a customized patient-centered, culturally appropriate colorectal cancer education, and nutrition education program reduce the risk for colorectal cancer among patients with type 2 diabetes? * What is the impact of a patient-centered, culturally appropriate colorectal cancer education, and nutrition education intervention program on colorectal cancer screening and dietary indices among patients with type 2 diabetes compared to outcomes with patients who do not receive the intervention (usual care)? Participants randomized to the intervention group will: * receive a customized patient-centered, culturally appropriate education program * participate in eight (8) education sessions * be given booklet with colorectal cancer education and nutrition education to use as a workbook Researchers will compare colorectal cancer knowledge, perceptions, self-care, and social norms scores and dietary indices of the intervention group to the control group immediately and 6-months post intervention to see if the education program increased colorectal cancer knowledge and screenings and changes in dietary habits.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 1 Mar 2023
- Start date
- 1 May 2023
- Primary completion date
- Dec 2025
- Lead sponsor
- Charles Drew University of Medicine and Science
- Diseases
- Colorectal cancer, Type 2 diabetes
- NCT number
- NCT05765214
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 1 May 2023 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of colorectal cancer
- History of colectomy
- History of colonic polyps (ICD-10 Z86.010)
- History of radiation treatment for another cancer (abdominal prostate, skin etc)
- History of Crohn's disease
- Cognitive impairment or inability to comprehend or provide consent to participate in the study
Other
- Ulcerative colitis
- Cystic fibrosis
- \<10 year life expectancy
- Being institutionalized
- Participating in another diet program
Who the study is looking for
- Diabetes type 2 diagnosis
- Age 35-75
- Any gender
- African American race (Hispanic or non-Hispanic)
- Hispanic ethnicity (any race)
- Have had at least one visit to KCHC in the past 2 years
- Have complete address and telephone number in the electronic health records. Although USPSTF and American Cancer Society screening guidelines recommend starting screening at age 45, our intervention will include patients age 35-44 due to the reported incidence of CRC at an earlier age among diabetic patients 3
Age in the registry: 35 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charles R. Drew University Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.